Pivot Accelerates Development of CBD Products for Domestic Pet Market

Based on RTIC Ready-To-Infuse-Cannabis Powder and Thrudermic Transdermal Cream
VANCOUVER, May 18, 2018 /PRNewswire/ – Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) (“Pivot” or the “Company”) is pleased to announce that it has accelerated development of several…